Exhibition floorplan and list
You will find below the exhibition floorplan and exhibitors details:
3GEN INC./ DERMLITE
Stand(s) : 5
31521 Rancho Viejo Rd., #104
92675 San Juan Capistrano
3Gen manufacturers the DermLite brand of skin imaging devices.
Stand(s) : 20
Ronda del General Mitre, 151
Almirall is a leading skin-health focused global pharmaceutical company that partners with healthcare professionals, applying Science to provide medical solutions to patients & future generations.
ALTRUIST DERMATOLOGIST SUNSCREEN
Stand(s) : 18
Westerbeek van Eerten David
ME20 6SQ Kent
Altruist provides dermatologist specification sunscreen at the lowest possible price with the aim of reducing the incidence of skin cancer.
Created by Dr Andrew Birnie, Consultant Dermatologist.
10p/product is given to people with albinism in Africa.
Available through amazon.co.uk & amazon.es/it/de
Stand(s) : 9
3401 Princeton Pike
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
CANFIELD SCIENTIFIC GMBH
Stand(s) : 16
Canfield Scientific, Inc. is the global leader in developing and distributing industry-leading imaging and photographic systems for medical and aesthetic practices, hospitals, skin care and wellness centers, spas and medical spas.
EADO (EUROPEAN ASSOCIATION OF DERMATO-ONCOLOGY)
Stand(s) : 19
EADO (European Association of Dermato-Oncology) is an independent non-profit organization dedicated to promote, coordinate and improve clinical and laboratory research activities in the field of skin cancer including primary and secondary prevention, early detection, clinical diagnosis and clinical.
F. HOFFMANN-LA ROCHE
Stand(s) : 10
Koppitsch Mcmanus Michelle
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment.
Stand(s) : 14
Via Pian Scairolo 9
Helsinn, is a privately owned pharmaceutical group with a unique licensing business model and a robust portfolio of marketed cancer care products and development pipeline. Since 1976, Helsinn has been improving the everyday lives of patients guided by core family values: respect, integrity, quality.
Stand(s) : 4
Via Parmenide 10/a
IGEA improves patient’s Quality of Life developing and producing innovative, effective and safe therapeutic systems for clinical practice in Oncology. Cliniporator® and Cliniporator® VITAE are the most advanced electroporation technologies to treat tumour nodules to skin, subcutaneous tissue, parenchyma and bone.
Stand(s) : 17
101 Park Drive, Milton Park, Abingdon
OX14 4RY Oxford
Immunocore, a leading T Cell Receptor (TCR) biotechnology company, working to create first-in-class biological therapies that have the potential to transform patients’ lives. The Company’s primary therapeutic focus is oncology and it also has programs in infectious and autoimmune diseases.
Stand(s) : 7,6
Largo U. Boccioni 1
Novartis Oncology is inspired by patients to revolutionize the research, development and manufacturing of innovative, high quality medicines that help to improve and extend people’s lives.
Stand(s) : 12,13
45, place Abel Gance
92654 Boulogne Billancourt
Pierre Fabre is a French multinational, pharmaceutical and dermo-cosmetic company, and 86%-owned by a government-recognized public-interest foundation. Oncology is one of our priorities, with programs in therapeutic areas of high unmet medical need, including hemato-oncology and dermato-oncology
SANOFI GENZYME AND REGENERON
Stand(s) : 10bis
50 Binney Street
02142 Cambridge, MA
Sanofi Genzyme, a global healthcare leader, discovers and distributes therapeutic solutions focused on patients’ needs. Regeneron, a leading biopharmaceutical company, discovers, develops, manufactures, and commercializes biologic medicines for serious medical conditions. Since 2007, Sanofi Genzyme
Stand(s) : 3
Pyun Sung Hyun
310 De Guigne Dr
Speclipse, Inc. has developed a transformative, patented technology for real-time, non-invasive, in-vivo cancer diagnosis utilizing laser spectroscopy and machining learning algorithms. Clinical trials of Spectra-Scope in US and Australia have shown sensitivity of 95% and specificity of 87.
Stand(s) : 2,1
Within Sun Pharmaceuticals we focus on meeting the needs of patients & physicians. Our operations in Europe are supported by global R&D and manufacturing with an unwavering commitment to quality.